[Pharmacokinetic studies on the intravenous suspension of a new hepatosplenography agent (author's transl)].
D000100:Acetrizoic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D000818:Animals; D003287:Contrast Media / Q000378:metabolism*; D007275:Injections, Intravenous; D007700:Kinetics; D008099:Liver / Q000000981:diagnostic imaging*; D008297:Male; D011859:Radiography; D051381:Rats; D013154:Spleen / Q000000981:diagnostic imaging; D013535:Suspensions
D003287:Contrast Media; D013535:Suspensions; D000100:Acetrizoic Acid; C030421:2,4,6-triiodo-3-acetamidobenzoic acid (N-cyclohexylcarbamyloxy)ethyl ester